1. Preclinical in vivo activity of 2′,2′-difluorodeoxycytidine (gemcitabine) against human head and neck cancer;Braakhuis;Cancer Res,1991
2. Evaluation of the antitumor activity of gemcitabine (2′,2′-difluoro-2′-deoxycytidine);Hertel;Cancer Res,1990
3. A phase I clinical, plasma and cellular pharmacology study of gemcitabine;Abbruzzese;J Clin Oncol,1991
4. Phase II study of gemcitabine in non small cell lung cancer (NSCLC);Anderson,1991
5. Gemcitabine (2′,2′-difluorodeoxycytidine)—a novel antineoplastic agent with activity in both lung- and ovarian cancer;Hansen;Ann Oncol,1992